Turning Point Therapeutics
Turning Point Therapeutics, Inc. is a clinical-stage drug design company that specializes in the discovery and development of targeted cancer therapies
7
Funding Rounds
$720.7m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ji****** Je** Cu* | - | - | |
| Yi**** (P***** Li | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa***** Ma***** | - | - | - |
| At**** Co*********** | - | - | |
| Ga*** Ni******* | - | - | |
| Si**** Ge**** | - | - | - |
| Ma** Al*** | - | - | |
| Ca*** Ga******* | - | - | |
| Ba***** Bo*** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Turning Point Therapeutics has raised a total of $99.4m in funding over 7 rounds.
Key Insights:
- Turning Point Therapeutics Venture round, October 19, 2018: $80m
- Turning Point Therapeutics Series B round, March 21, 2016: $18m
- Turning Point Therapeutics Venture round, January 6, 2014: $1.4m
- Turning Point Therapeutics Venture round, September 2019: $202.5m
- TP Therapeutics funding round, May 2017: $45m
- Turning Point Therapeutics Venture round, May 2020: $373.8m
Turning Point Therapeutics Venture round, October 19, 2018
$80m
Turning Point Therapeutics Series B round, March 21, 2016
$18m
Turning Point Therapeutics Venture round, January 6, 2014
$1.4m
Turning Point Therapeutics Venture round, September 2019
$202.5m
TP Therapeutics funding round, May 2017
$45m
Turning Point Therapeutics Venture round, May 2020
$373.8m
Industries
Turning Point Therapeutics is active in the following industries:
- Engineering
- Consumer biotechnology
- Cancer
- Enzyme kinetics
- Biopharmaceutical
- Therapeutics
- Biotechnology
- Biology
- Biomedical engineering
- Technology